About Us
In the News
Press Releases & Publications
2024
February 6, 2024
2023
November 20, 2023
Overcoming Bioprocessing Bottlenecks By Combining Adherent And Suspension Systems (cellandgene.com)
July 26, 2023
Bridging the Gap: How WB is Helping to Translate Research from Bench to Bedside
2022
July 5, 2022
March 3, 2022
February 22, 2022
2021
June 15, 2021
FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns
2020
December 18, 2020
The Pace of a Pandemic Meets the Speed of Science As Wisconsin Takes On COVID-19
October 28, 2020
September 14, 2020
September 9, 2020
Waisman Biomanufacturing partners with GigaGen to manufacture new COVID-19 drug
September 2, 2020
UW partners with biotech company to develop COVID-19 vaccine
August 3, 2020
UW connected company to manufacture COVID-19 vaccine
UW-Madison company to manufacture COVID-19 vaccine
Madison company to manufacture COVID-19 vaccine
UW lab partners with North Carolina company on COVID-19 vaccine
July 30, 2020
Cynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive Results
May 27, 2020
Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
March 17, 2020
Stem Cell Therapy Trial Offers Hope To Osteoarthritis Patients
March 16, 2020
WHV completes manufacturing of DNA vaccine components
January 15, 2020
2019
December 13, 2019
CLINICAL TRIAL FOR EBOLA VACCINE DEVELOPED AT UW–MADISON UNDERWAY IN JAPAN
August 12, 2019
2018
November 18, 2018
Artery banks may transform how we fight heart disease
November 4, 2018
Stem cell therapy developed at UW-Madison tested in clinical trial
October 4, 2018
Department of Defense grant for clinical trial of stem cell therapy for eye injuries
May 11, 2018
UW-Madison biomanufacturer offers essential gene-transfer capacity
March 26, 2018
UMass Medical School HIV vaccine to be tested in new Phase I trial
February 27, 2018
UW-Madison lab to make Ebola vaccine
February 27, 2018
Excellent Cohort A Data from Final Primary Evaluation Period in Cynata GvHD Phase 1 Clinical Trial
February 21, 2018
Ebola vaccine inches toward human clinical trials
2017
September 27, 2017
Aduro Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Personalized Immunotherapy pLADD Based on Proprietary Neoantigen Technology
September 12, 2017
UW–Madison to partner in $20 million cell-based therapy center
August 2, 2017
July 5, 2017
Cynata Therapeutics : 17.07.05.FDA Meeting Provides Clear Path for US Development Plans
May 16. 2017
Patient Treatment Commences in Cynata’s World First Clinical Trial
2016
November 16, 2016
Morgridge–UW project investigates tissue-engineered arteries for transplant
November 9, 2016
Can artery ‘banks’ transform vascular medicine?
September 20, 2016
Cynata Approved to Launch World’s 1st Clinical Trial with an Allogeneic iPSC-Derived Product
August 1, 2016
June 22, 2016
UMMS receives $17.3 million to oversee manufacturing of HIV vaccine
April 7, 2016
Cynata Reports Compelling Results from Pre-clinical Stem Cell Study in Graft-versus-Host Disease (GvHD)
February 18, 2016
January 28, 2016
Cynata Receives Favourable Advice from UK Regulatory Authority – Prepares to Initiate Clinical Trial of 1st Allogenic iPSC-derived MSC Product
2015
September 15, 2015
Madison Vaccines Says Clinical Trial Begins for Its 2nd Prostate Cancer Vaccine, MVI-118, Intended to Delay Disease Progression in Men with Metastatic Disease
February 19, 2015
Cynata Achieves Major Stem Cell Manufacturing Milestone
2014
July 21, 2014
May 29, 2014
April 2014 - CTS Publication, Volume 7, Issue 2
April 11, 2014
February 16, 2014
Induced pluripotent stem cells as custom therapeutics for retinal repair: Progress and rationale
February 10, 2014
Cynata Partners With Leading Biologic Product Manufacturer
January 14, 2014
Spinoff joins fight against prostate cancer
2013
December 13, 2013
A new approach using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19
October 2013 - ISCT Newsletter, Volume 20, No. 5
PACT Update: Cell Therapy for Regeneration of the Vocal Fold
October 17, 2013
Biomanufacturing center takes central role in developing stem-cell therapies
October 3, 2013
Banking Human Induced Pluripotent Stem Cells: Lessons Learned from Embryonic Stem Cells?
April 12, 2013
UW Stem Cell Researchers Building a 'Retinal Patch' to Restore Vision
February 10, 2013
Tom Still: Waisman Center's Four Decades of Research Changes Lives
2012
April 3, 2012
Madison researchers making major breakthroughs in stem cell work
March 11, 2012
January 21, 2012
Biomanufacturing Facility Adopts New Approach to Sterile Cleanroom Gowning
2010
November 17, 2010
Madison biotech company Stratatech awarded $3.5 million grant for cell therapy project being done in partnership with Waisman Biomanufacturing
May 14, 2010
The Problems and Promises of Stem Cell Research
March 3, 2010
NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT)
February 17, 2010
Law, Ethics, Religion, and Clinical Translation in the 21st Century—A Discussion with Derek Hei
January 26, 2010
Federal grant funds productions of stem cells for clinical trials
November/December 2009 - ICTRToday Newsletter, Volume 2, No. 6
Waisman Biomanufacturing Facility Speeds Clinical Translation
2009 and earlier
September 17, 2009
(Stem cell) banking crisis
May 29, 2009
Waisman Clinical Biomanufacturing Facility and Nature Technology Team up on DNA Therapeutics Manufacturing
March 10, 2009
UW-Madison stem cell experts visit White House
December 15, 2005
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates
August 29, 2005
UW's Waisman Center seeing strong demand for biomanufacturing facility time
May 9, 2000
Facility to bridge gap between discovery, therapy